Edition:
United Kingdom

Cancer Genetics Inc (CGIX.OQ)

CGIX.OQ on NASDAQ Stock Exchange Capital Market

0.90USD
22 Jun 2018
Change (% chg)

$-0.10 (-9.99%)
Prev Close
$1.00
Open
$0.99
Day's High
$0.99
Day's Low
$0.90
Volume
56,330
Avg. Vol
94,680
52-wk High
$4.25
52-wk Low
$0.83

Chart for

About

Cancer Genetics, Inc. is a United States-based company, which is engaged in the field of personalized medicine. The Company offers diagnostic products and services that enable precision medicine in the field of oncology through molecular markers and diagnostics. The Company offers a range of laboratory services that provide... (more)

Overall

Beta: 1.22
Market Cap(Mil.): $53.93
Shares Outstanding(Mil.): 19.79
Dividend: --
Yield (%): --

Financials

  CGIX.OQ Industry Sector
P/E (TTM): -- 28.41 32.74
EPS (TTM): -1.02 -- --
ROI: -57.22 6.42 14.38
ROE: -78.97 10.07 16.08

BRIEF-Cancer Genetics Says Appointed John Roberts As CEO And President

* CANCER GENETICS SAYS ON APRIL 30, BOARD APPOINTED JOHN ROBERTS AS COMPANY'S CEO AND PRESIDENT - SEC FILING Source: (https://bit.ly/2w2ruOW) Further company coverage:

01 May 2018

BRIEF-Cancer Genetics Reports Q4 Loss Per Share Of $0.35

* CANCER GENETICS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS AND PROVIDES STRATEGIC BUSINESS UPDATES

02 Apr 2018

BRIEF-Cancer Genetics Receives Non-Dilutive Funding Of $1.1 Mln

* CANCER GENETICS RECEIVES NON-DILUTIVE FUNDING OF $1.1 MILLION THROUGH NEW JERSEY TECHNOLOGY BUSINESS TAX CERTIFICATE TRANSFER (NOL) PROGRAM

28 Dec 2017

Earnings vs. Estimates